Wyoming Administrative Code
Agency 059 - Pharmacy, Board of
Sub-Agency 0001 - Pharmacy, Board of
Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS
Section 12-19 - Investigational Drugs and Protocols

Universal Citation: WY Code of Rules 12-19

Current through September 21, 2024

(a) All investigational drugs shall be stored in the institutional pharmacy and distributed only from the institutional pharmacy. Basic information concerning the dosage form, route of administration, strength, actions, uses, side effects, adverse effects, interactions, and symptoms of toxicity of such drugs shall be available in the institutional pharmacy. investigational drugs shall be properly labeled and shall be administered only under the personal and direct supervision of the principal physician-investigator or his or her authorized clinician(s) with prior approval of the appropriate committee(s) of the institutional facility and with verifications that the patient (or his or her legal designee) has signed the informed consent form.

(b) A copy of all investigational drug protocols shall be on file in the institutional pharmacy.

Disclaimer: These regulations may not be the most recent version. Wyoming may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.